Article
Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors.
Journal of geriatric oncology - 1 Jan 2021
Hakozaki Taiki, Matsuo Takuma, Shimizu Akihiro, Ishihara Yoko, Hosomi Yukio
Abstract excerpt
OBJECTIVE: Polypharmacy (PP) is a common problem among the older adults and has a potential effect on health-related problems. However, the significance of PP in older advanced non-small cell lung cancer (NSCLC) patients and those on oral molecular-targeted anticancer agents is unclear. MATERIALS AND METHODS: This retrospective, nonrandomized study reviewed the records of 334 advanced NSCLC patients who underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
